Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
Helius Medical Technologies Inc (NASDAQ: HSDT) closed the day trading at $1.14 down -65.14% from the previous closing price of $3.27. In other words, the price has decreased by -$65.14 from its previous closing price. On the day, 29.22 million shares were traded.
Ratios:
For a better understanding of HSDT, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.13 and its Current Ratio is at 1.69. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Noble Capital Markets on March 24, 2021, initiated with a Outperform rating and assigned the stock a target price of $20.
Stock Price History:
Over the past 52 weeks, HSDT has reached a high of $24.00, while it has fallen to a 52-week low of $3.00. The 50-Day Moving Average of the stock is -74.53%, while the 200-Day Moving Average is calculated to be -85.67%.
Shares Statistics:
A total of 0.53M shares are outstanding, with a floating share count of 0.52M. Insiders hold about 0.93% of the company’s shares, while institutions hold 2.56% stake in the company.
